Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06169579
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-03-21
First Post:
2023-11-23
Brief Title:
An Open-label Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
Sponsor:
Shenzhen NewDEL Biotech Co Ltd
Organization:
Shenzhen NewDEL Biotech Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumor |
Keywords: